Alto Neuroscience, Inc.
USD26.29
-1.78 (-6.34%)
CEO
Amit Etkin
IPO Date
2024-02-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$28.06
Prev. Close
$28.07
Day Low
$26.18
Day High
$28.07
52W Low
$2.20
52W High
$28.44
Market Cap
$0.92B
Volume
0.32M
| 0 |
| $0.00 |
| 15 May 2026 | Etkin Amit | director, officer: PRESIDENT AND CEO | G-Gift | Disposed | 400,000 | $0.00 |
| 14 May 2026 | Sanchez Ramiro | director | A-Award | Acquired | 10,958 | $24.63 |
| 14 May 2026 | Cox Christopher Nixon | director | A-Award | Acquired | 10,958 | $24.63 |
| 14 May 2026 | Manji Husseini | director | A-Award | Acquired | 10,958 | $24.63 |
| 14 May 2026 | Dreyfus Andrew | director | A-Award | Acquired | 10,958 | $24.63 |
| 14 May 2026 | York Gwill | director | A-Award | Acquired | 10,958 | $24.63 |
| 3 Mar 2026 | Etkin Amit | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 6,227 | $19.69 |
| 3 Mar 2026 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | F-InKind | Disposed | 2,806 | $19.69 |